Jeffrey Laurence (J Laurence)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Venues

Bone marrow transplantation

Clinical and experimental immunology

Journal of thrombosis and haemostasis : JTH

NewYork-Presbyterian Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NewYork-Presbyterian Hospital Jul 01 1982

United States

Attending Physician :: Medicine

Joan and Sanford I Weill Medical College of Cornell University Jul 01 1982

United States

Professor :: Medicine

Publications

Mohammad Alhomoud, Cynthia Magro, Surya Seshan, Taotao Zhang, Alexandra Gomez-Arteaga, Nora Chokr, Samuel Yamshon, Adrienne Phillips, Sebastian Mayer, Tsiporah B Shore, Jeffrey Laurence
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation. Bone marrow transplantation (2023)
Sonia Elhadad, Amy Chadburn, Cynthia Magro, Koen van Besien, Elisha D O Roberson, John P Atkinson, Hunter Terry, June Greenberg, Whitney Reid, John Chapin, Dennis C Copertino, Sahar Geramfard, Lizamarie Bachier Rodriguez, Nina Orfali, Usama Gerghis, Tsiporah B Shore, Sebastian Mayer, Jasimuddin Ahamed, Jeffrey Laurence
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone marrow transplantation 57 (9) (2022)
Sandeep Subrahmanian, Alain Borczuk, Steven Salvatore, Kar-Ming Fung, Joan T Merrill, Jeffrey Laurence, Jasimuddin Ahamed
Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients. Journal of thrombosis and haemostasis : JTH 19 (9) (2021)
S Elhadad, J Chapin, D Copertino, K Van Besien, J Ahamed, Jeffrey Laurence
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. Clinical and experimental immunology 203 (1) (2020)

Jeffrey Laurence.css-eqlu8i{font-size:small;padding-left:4px;} (J Laurence)

Publication Activity (10 Years)

Top Topics

Top Venues

Jeffrey Laurence (J Laurence)